Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -136.72M
March 31, 2026 -81.28M
December 31, 2025 -76.58M
September 30, 2025 -77.67M
June 30, 2025 -85.19M
March 31, 2025 -191.15M
December 31, 2024 -197.31M
September 30, 2024 -208.73M
June 30, 2024 -220.31M
March 31, 2024 -192.14M
December 31, 2023 -205.80M
September 30, 2023 -204.62M
June 30, 2023 -209.49M
March 31, 2023 -212.61M
December 31, 2022 -214.12M
September 30, 2022 -217.86M
June 30, 2022 -207.99M
March 31, 2022 -187.51M
Date Value
December 31, 2021 -164.76M
September 30, 2021 -152.10M
June 30, 2021 -135.17M
March 31, 2021 -123.34M
December 31, 2020 -117.19M
September 30, 2020 -139.93M
June 30, 2020 -146.79M
March 31, 2020 -146.50M
December 31, 2019 -140.67M
September 30, 2019 -107.67M
June 30, 2019 -96.29M
March 31, 2019 -86.00M
December 31, 2018 -76.94M
September 30, 2018 -71.24M
June 30, 2018 -68.44M
March 31, 2018 -65.14M
December 31, 2017 -62.71M
September 30, 2017 -59.31M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Intellia Therapeutics, Inc. -399.98M
Beam Therapeutics, Inc. -85.43M
Prime Medicine, Inc. -187.89M
Absci Corp. -121.08M
10X Genomics, Inc. -75.12M